General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Alnylam Pharmaceuticals(MODEST), Ionis pharmaceuticals(MODEST), Eidos (SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Alnylam Pharmaceuticals(MODEST)
CONSULTING FEES/HONORARIA: Alnylam Pharmaceuticals(MODEST), Ionis pharmaceuticals(MODEST), Eidos (SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Alnylam Pharmaceuticals(MODEST)
© 2025 American College of Cardiology Foundation. All rights reserved.
